Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Institute for Systems Biology, Agilent Technologies to Build MRM Atlas for Quantification of All Human Proteins

Published: Monday, October 26, 2009
Last Updated: Monday, October 26, 2009
Bookmark and Share
The project is expected to fuel important research gains in biomarker discovery and validation, personalized medicine, and human health monitoring.

The Institute for Systems Biology (ISB) and Agilent Technologies Inc. has announced a collaboration to create the Human Multiple Reaction Monitoring (MRM) Atlas, a comprehensive resource designed to enable scientists to perform quantitative analysis of all human proteins.

The project is expected to fuel important research gains in biomarker discovery and validation, the search for protein-based diagnostic tests, personalized medicine, and human health monitoring.

The program is supported by grants totaling $4.6 million to ISB’s Robert Moritz and Leroy Hood for developing the “Complete Human Peptide and MRM Atlas” by the National Human Genome Research Institute of the National Institutes of Health, under “The American Recovery and Reinvestment Act – Grant Opportunities.” Ruedi Aebersold of the Swiss Federal Institute of Technology (ETH) Zurich is collaborating as well, with additional funding from the European Research Council.

The work, occurring over two years, will be performed using Agilent triple quadrupole and quadrupole time-of-flight liquid chromatography/mass spectrometry (LC/MS) systems and nanoflow HPLC-Chip/MS systems at ISB in Seattle and at ETH Zurich.

“We believe this will be a revolutionary development in protein analysis,” said Rob Moritz, ISB faculty member and director of Proteomics, “one that will accelerate and catalyze the routine use of protein quantitation for immensely important breakthroughs in the understanding, early detection and monitoring of human disease.”

“Agilent is pleased to share leadership in creating the Human MRM Atlas and MRM-based methods to support quantitative protein research,” said Ken Miller, Agilent director of LC/MS marketing. “The combination of our triple quadrupole instrumentation, software tools specific for protein analysis, and unique HPLC-Chip/MS technologies creates a stable, sensitive platform for the analysis of these large sample sets.”

The MRM Atlas is designed to enable scientists to quantitatively access the approximately 20,000 proteins in human tissues, cell lines and blood, potentially transforming many areas of human health research. The project will produce a database of up to four peptides per human protein-coding gene, with verified MRM-based mass spectrometric assays to enable the identification and quantification of almost any protein in the human proteome. It is expected to benefit general biology research and large-scale proteomic studies.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent’s 2014 Early Career Professor Award Supports Biomedical Research
Dr. Paul Blainey recognized for work in single-cell measurement, analysis.
Saturday, May 24, 2014
Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella
Project also seeks to develop better tools to test truth of seafood labels.
Monday, March 26, 2012
Agilent Technologies’ Exome Target-Enrichment System to Analyze 1,500 Samples in Erasmus Genetic Population Study
Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part to identify genetic risk factors for some complex genetic disorders.
Thursday, March 08, 2012
Agilent and Monash University Sunway Campus Collaborate
Latest technologies to strengthen university’s investigations into diabetes, cancer, neurobiology and infectious diseases.
Friday, December 09, 2011
Agilent and Oxford Gene Technology Expand Partnership
Agilent to provide OGT with oligonucleotide microarrays and SureSelect target enrichment products for sequencing.
Tuesday, October 18, 2011
Agilent Appoints Molecular Genomics as its First Certified Service Provider for Microarrays in Singapore
Molecular Genomics offers microarray services using the Agilent CGH/SNP microarrays, gene expression, and microRNA products.
Monday, July 25, 2011
Agilent Appoints NIMGenetics as Spain’s First Certified Service Provider for CGH and CGH/SNP Microarrays
NIMGenetics has achieved CSP status for genomic research using Agilent SurePrint comparative genomic hybridization and CGH/SNP microarrays.
Thursday, May 19, 2011
Agilent Appoints Beckman Coulter Genomics First CSP for Target Enrichment and Microarrays
Beckman now is certified to perform SureSelect target enrichment upstream of both the AB SOLiD and Illumina Genome Analyzer sequencers.
Monday, November 08, 2010
Agilent Technologies’ Microfluidics System Used in Breakthrough Breast Milk Study
Company’s HPLC-Chip and QTOF LC/MS technology provided researchers a new view of the oligosaccharide structures produced in breast milk.
Wednesday, August 18, 2010
Agilent Technologies Extends Million-Feature Format to Gene Expression Microarrays
Agilent SurePrint G3 Gene Expression Microarrays provides up to one million features per standard 1-by-3-inch slide for added throughput.
Tuesday, May 18, 2010
Agilent Microarray Manufacturing Achieves ISO 13485 Compliance; Cytogenetics Platform Poised to Pursue FDA 510(k) Clearance
Agilent Technologies Inc. today announced that its entire portfolio of DNA microarrays is now manufactured under ISO 13485 certification, an internationally recognized standard for quality management systems (QMS).
Thursday, March 25, 2010
Agilent Technologies Announces New Leadership in Biological Systems Division
Company appoints Robert Schueren as VP and GM of Genomics; and John Fjeldsted, Ph.D., as GM of LC/MS.
Wednesday, February 17, 2010
Dolan DNA Learning Center Adopts Agilent Lab-on-a-Chip System to Teach DNA Techniques
CSHL’s learning center adopts the Agilent 2100 Bioanalyzer system to teach high school students and teachers how to analyze DNA.
Friday, August 14, 2009
Agilent Technologies’ Custom-Designed CGH Microarray Used to Map Korean Genome
Scientists using an Agilent custom-designed comparative genomic hybridization array have sequenced the entire gene map of a Korean male.
Wednesday, July 22, 2009
Phytronix and Agilent to Co-Market Phytronix LDTD Ion Source with Agilent Mass Spectrometers
The non-exclusive co-marketing agreement aims to promote the Phytronix Laser Diode Thermal Desorption Ion Source with Agilent mass spectrometers.
Wednesday, June 10, 2009
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Capturing Cell Growth in 3-D
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
Device May Detect Urinary Tract Infections Faster
A Lab-on-a-Disc platform developed by a German and Irish team of researchers dramatically cut the time to detect bacterial species that cause urinary tract infections -- a major cause of sepsis.
Automation Abound at AACC in Atlanta
Discover the latest breakthroughs, trends and products from the AACC Annual Meeting & Clinical Lab Expo.
Real-Time Data for Cancer Therapy
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!